Arbutus Biopharma (ABUS) Goodwill (2015 - 2019)

Arbutus Biopharma (ABUS) has reported Goodwill for 5 consecutive years, with $22.5 million the latest figure, recorded in Q2 2019.

• Quarterly Goodwill changed 0.0% year-over-year to $22.5 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $22.5 million (changed 0.0% YoY) and the FY2018 annual result came in at $22.5 million, down 7.77% from the prior year.
• Goodwill was little changed at $22.5 million in Q2 2019 per ABUS's latest filing, from $22.5 million in the prior quarter.
• Over the last five years, Goodwill for ABUS reached as high as $162.5 million in Q4 2015 and fell as low as $22.5 million in Q2 2018.
• A 5-year average of $76.5 million and a median of $24.4 million in 2016 frame the typical range for Goodwill.
• The largest YoY upside for Goodwill was 4.27% in 2016 against a maximum downside of 85.01% in 2016.
• Year by year, Goodwill stood at $162.5 million in 2015, then tumbled by 85.01% to $24.4 million in 2016, then changed by 0.0% to $24.4 million in 2017, then fell by 7.77% to $22.5 million in 2018, then changed by 0.0% to $22.5 million in 2019.
• According to Business Quant data, Goodwill over the past three periods registered $22.5 million, $22.5 million, and $22.5 million for Q2 2019, Q1 2019, and Q4 2018 respectively.